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Background:
Daniel Barnas, MD; Aaron Bleznak, MD; Anna Widmyer, MD; Elizabeth Dellers, MD; Heiwon Chung, MD
Receiver Operating Characteristic Curve
for Margin Index >5•  Breast conserving surgery combined with radiation therapy standard 
treatment in early stage breast cancer
•  Long term survival equivalent to mastectomy
•  20-60% of patients require a second operation because of inadequate 
margins
•  Local recurrence impacted by many factors
•  Strongest predictor
Surgical Margin:
•  No consensus on definition of 
negative margin
•  Currently 2-3 mm up to 5 mm 
for DCIS
 Trial Margin
 NSABP B-06 Tumor on Ink
NIH and Danish Did not require assessment




•  To determine if definition of negative margin should be redefined
•  Use margin distance to stratify risk of residual disease
Margin Index:
•  Margin Index = closest margin (mm)/tumor size (mm) x 100
•  475 patients stage I-II treated with BCT
•  Underwent re-excision for close margins
•  102 (21%) had residual disease on re-excision
•  Optimum Margin Index ≥5
•  Sensitivity 85% and Specificity 73%
•  Identify patients who need re-excision
Methods:
•  Single institution review
•  Retrospective analysis of our database of 95 patients who underwent 
re-excision from 2008-2009
•  Tumor size was assessed microscopically
•  Closest margin distance was used
•  Margin Index was calculated
•  A receiver operating characteristic curve was created
Patient Characteristics:
•  217 patients; 95 had re-excision (43%)
•  88 had sufficient data for QI study
•  41 patients had close margins
•  Stage I and II disease
•  8 (19.5%) positive on re-excision
•  Median Age: 55
•  Median Tumor Size: 2 cm
•  Average margin distance 0.91 mm
•  Median Margin Index 2.78 Conclusions:
•  Not a superior predictor over margin distance
•  Limitations
  –  Small Sample Size
  –  Retrospective 
  –  Selection Bias
  –  Small number of patients margin >1mm  
•  Continue to use current treatment guidelines
•  Further research to determine adequate margins




% Patients with 
Residual Disease 
on Re-excision
 <1mm 28 6 21%
1-2mm 7 1 14%









 Margin Index <5 4 12 16
Margin Index >5 4 21 25
Total Patients 8 33 41





Area Under the Curve 0.568
Receiver Operating Characteristic Curve
for Margin Index >3





































Curve for Margin Index ≥ 3
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